| New chronic hepatitis C (HCV) infections (number) WHO | WHO | – |
| People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number) WHO | WHO | +11.7% |
| Hepatitis - Deaths caused by chronic hepatitis B and C WHO | WHO | – |
| Chronic hepatitis C (HCV) infected persons diagnosed (number) WHO | WHO | −39.1% |
| Eligible women attending antenatal care who were treated for HBV WHO | WHO | – |
| Health care expenditure by provider Eurostat | Eurostat | +5.9% |
| Health care expenditure by function Eurostat | Eurostat | +1.2% |
| Health care expenditure by function Eurostat | Eurostat | −1.4% |
| Health care expenditure by function Eurostat | Eurostat | −2.7% |
| Expenditure for selected health care functions by health care financing schemes Eurostat | Eurostat | −3.8% |
| Expenditure for selected health care functions by health care providers Eurostat | Eurostat | +4.3% |
| Health care expenditure by financing scheme Eurostat | Eurostat | +3.3% |
| Health care expenditure by financing scheme Eurostat | Eurostat | +0.6% |
| Expenditure for selected health care providers by health care financing schemes Eurostat | Eurostat | +7.2% |
| Out-of-pocket expenditure on healthcare Eurostat | Eurostat | −0.2% |
| Total health care expenditure Eurostat | Eurostat | +2.7% |
| Long-term care (health) expenditure Eurostat | Eurostat | +10.6% |
| Causes of death - infant mortality by country of occurrence Eurostat | Eurostat | 0 |
| Peri-neonatal mortality by age of mother, by residence and occurrence Eurostat | Eurostat | 0 |
| Fetal, peri- and neonatal mortality rates by country of occurrence Eurostat | Eurostat | 0 |
| Deaths related to infectious diseases Eurostat | Eurostat | 0% |
| Deaths related to transport accidents occurring in the country Eurostat | Eurostat | 0 |
| International Health Regulations core capacity scores, SPAR version, 2nd edition WHO | WHO | +3.8% |
| Deaths by age, sex and legal marital status Eurostat | Eurostat | 0% |
| Inpatient curative care bed occupancy rate by type of care Eurostat | Eurostat | +3% |
| Medical technologies - examinations by medical imaging techniques (CT, MRI and PET) Eurostat | Eurostat | +11.6% |
| Hospital discharges and length of stay for inpatient curative care Eurostat | Eurostat | +4.9% |
| Surgical procedures Eurostat | Eurostat | 0 |
| Consultation of a dentist per inhabitant Eurostat | Eurostat | 0% |
| Consultation of a medical doctor per inhabitant and by type of consultation Eurostat | Eurostat | −3% |
| Vaccination against influenza of population aged 65 and over Eurostat | Eurostat | 0% |
| Preventive cancer screenings - programme data Eurostat | Eurostat | +11.9% |
| Beds in nursing and other residential long-term care facilities Eurostat | Eurostat | −3.3% |
| Hospital beds by function and type of care Eurostat | Eurostat | +1.5% |
| Hospital beds by hospital ownership Eurostat | Eurostat | +1.5% |
| Health graduates Eurostat | Eurostat | 0 |
| Health graduates Eurostat | Eurostat | 0 |
| Devices for medical imaging Eurostat | Eurostat | +1.5% |
| Physicians by sex and age Eurostat | Eurostat | −2.1% |
| Physicians by category Eurostat | Eurostat | −2.2% |
| Physicians by NUTS 2 region Eurostat | Eurostat | +3.8% |
| Health personnel Eurostat | Eurostat | −1.6% |
| Health personnel Eurostat | Eurostat | +0.6% |
| Hospital employment Eurostat | Eurostat | +2.2% |
| Technical resources in hospital Eurostat | Eurostat | 0 |
| Health workforce migration Eurostat | Eurostat | 0% |
| Hospital beds Eurostat | Eurostat | −1.5% |
| Excess mortality by month Eurostat | Eurostat | −196.3% |
| Causes of death - years and potential years of life lost by NUTS 2 region of residence, 3 year average Eurostat | Eurostat | +28.5% |
| Standardised death rate due to tuberculosis, HIV and hepatitis by type of disease Eurostat | Eurostat | −2.1 |
| Death due to cancer, by sex Eurostat | Eurostat | −15.9% |
| Death due to other ischaemic heart diseases, by sex Eurostat | Eurostat | −1.3% |
| Death due to suicide, by sex Eurostat | Eurostat | −4.4 |
| Death due to accidents, by sex Eurostat | Eurostat | −75.7% |
| Death due to pneumonia, by sex Eurostat | Eurostat | −7.3% |
| Death due to chronic liver disease, by sex Eurostat | Eurostat | +93.4% |
| Death due to diseases of the nervous system, by sex Eurostat | Eurostat | −15.2% |
| Death due to diabetes mellitus, by sex Eurostat | Eurostat | −9.5 |
| Death due to alcoholic abuse, by sex Eurostat | Eurostat | 0 |
| Death due to AIDS (HIV-disease), by sex Eurostat | Eurostat | −4.1 |
| Death due to drugs dependence, by sex Eurostat | Eurostat | 0 |
| Causes of death, by sex Eurostat | Eurostat | −18.2% |
| Suicide death rate by age group Eurostat | Eurostat | 0 |
| Life expectancy at birth by sex Eurostat | Eurostat | −0.1% |
| Peri-neonatal mortality by age of mother and parity, by NUTS 2 region of residence and occurrence, 3 year average Eurostat | Eurostat | 0 |
| Current health expenditure (CHE) per capita in US$ WHO | WHO | +8.5% |
| Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%) WHO | WHO | +1.2% |
| External health expenditure (EXT) as percentage of current health expenditure (CHE) (%) WHO | WHO | 0 |
| Domestic general government health expenditure (GGHE-D) per capita in US$ WHO | WHO | +10.5% |
| Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%) WHO | WHO | +1.8% |
| Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%) WHO | WHO | +3.1% |
| Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%) WHO | WHO | −0.3% |
| Out-of-pocket expenditure (OOP) per capita in US$ WHO | WHO | +9.4% |
| Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%) WHO | WHO | +0.8% |
| Primary health care expenditure (PHCE) per сapita in US$ WHO | WHO | +7.2% |
| Domestic private health expenditure (PVT-D) per capita in US$ WHO | WHO | +4.5% |
| Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%) WHO | WHO | −3.7% |
| Causes of death - infant mortality by country of residence Eurostat | Eurostat | 0 |
| Treatable and preventable mortality of residents by cause and sex Eurostat | Eurostat | 0 |
| Causes of death - potential years of life lost by residence Eurostat | Eurostat | +28.5% |
| Deaths of residents related to dementias including Alzheimer Eurostat | Eurostat | 0% |
| Infant deaths occurring in the country by cause Eurostat | Eurostat | 0 |
| Standardised preventable and treatable mortality Eurostat | Eurostat | −25% |
| Causes of death - standardised death rate by NUTS 2 region of residence, 3 year average Eurostat | Eurostat | −2.7% |
| All causes of death by NUTS 2 region Eurostat | Eurostat | −3.4% |
| Death due to cancer by NUTS 2 region Eurostat | Eurostat | −3.8% |
| Death due to ischaemic heart diseases by NUTS 2 region Eurostat | Eurostat | −5.3% |
| Death due to accidents by NUTS 2 region Eurostat | Eurostat | −13.5% |
| Death due to transport accidents by NUTS 2 region Eurostat | Eurostat | −2.2% |
| Causes of death - deaths by country of residence and occurrence Eurostat | Eurostat | 0 |
| Causes of death - crude death rate by NUTS 2 region of residence Eurostat | Eurostat | – |
| Treatable and preventable mortality of residents by cause and sex Eurostat | Eurostat | +22.2% |
| Health impacts of air pollution Eurostat | Eurostat | −28.6% |
| Premature deaths due to exposure to fine particulate matter (PM2.5) Eurostat | Eurostat | −28.6% |
| Food safety IHR (%) WHO | WHO | – |
| People using safely managed drinking water services (% of population) World Development Indicators | World Development Indicators | 0% |
| Specialist surgical workforce (per 100,000 population) World Development Indicators | World Development Indicators | −26.1% |
| Diabetes prevalence (% of population ages 20 to 79) World Development Indicators | World Development Indicators | +53.2% |
| People using safely managed sanitation services (% of population) World Development Indicators | World Development Indicators | 0% |
| Mortality rate, adult, female (per 1,000 female adults) World Development Indicators | World Development Indicators | −0.5% |
| Mortality rate, adult, male (per 1,000 male adults) World Development Indicators | World Development Indicators | −3.7% |
| Life expectancy at birth, female (years) World Development Indicators | World Development Indicators | +2.3% |
| Life expectancy at birth, total (years) World Development Indicators | World Development Indicators | +0.9% |
| Survival to age 65, female (% of cohort) World Development Indicators | World Development Indicators | 0% |
| Survival to age 65, male (% of cohort) World Development Indicators | World Development Indicators | +0.3% |
| Population ages 75-79, female (% of female population) World Development Indicators | World Development Indicators | +1.1% |
| Population ages 75-79, male (% of male population) World Development Indicators | World Development Indicators | +1.8% |
| Population ages 80 and above, female (% of female population) World Development Indicators | World Development Indicators | +5% |
| Population ages 80 and above, male (% of male population) World Development Indicators | World Development Indicators | +9.2% |
| Congenital syphilis number of cases, reported WHO | WHO | 0 |
| Congenital syphilis rate per 100 000 live births, reported WHO | WHO | 0 |
| Number of people pushed below the 60% median consumption poverty line by out-of-pocket health care expenditure Health Nutrition and Population Statistics | Health Nutrition and Population Statistics | – |
| Number of people pushed or further pushed below the $2.15 ($ 2017 PPP) poverty line by out-of-pocket health care expenditure Health Nutrition and Population Statistics | Health Nutrition and Population Statistics | – |
| Number of people pushed or further pushed below the $3.65 ($ 2017 PPP) poverty line by out-of-pocket health care expenditure Health Nutrition and Population Statistics | Health Nutrition and Population Statistics | – |
| Number of people pushed or further pushed below the 60% median consumption poverty line by out-of-pocket health care expenditure Health Nutrition and Population Statistics | Health Nutrition and Population Statistics | – |
| Population ages 75-79, female Health Nutrition and Population Statistics | Health Nutrition and Population Statistics | +2% |
| Population ages 75-79, male Health Nutrition and Population Statistics | Health Nutrition and Population Statistics | +2.7% |
| Population ages 80 and above, female Health Nutrition and Population Statistics | Health Nutrition and Population Statistics | +5.9% |
| Reported cases of chlamydia (number) WHO | WHO | 0% |
| Reported cases of gonorrhea (number) WHO | WHO | 0% |
| Reported cases of syphilis (number) WHO | WHO | −33.3% |
| Africa's Development Dynamics (AfDD) Table 13 - Basic health indicators OECD | OECD | +0.1% |
| Policy, Legal and normative Instruments to implement IHR WHO | WHO | −10% |
| IHR Coordination, National IHR Focal Point functions and advocacy WHO | WHO | −20% |
| Financing WHO | WHO | 0% |
| Laboratory WHO | WHO | −4% |
| Surveillance WHO | WHO | +11.1% |
| Human resources WHO | WHO | 0% |
| Health emergency management WHO | WHO | 0% |
| Health services provision WHO | WHO | −6.5% |
| Infection prevention and control (IPC) WHO | WHO | +11.7% |
| Risk communication and community engagement (RCCE) WHO | WHO | −8% |
| Points of entry (PoEs) and border health WHO | WHO | 0 |
| Zoonotic diseases WHO | WHO | 0% |
| Food safety WHO | WHO | 0% |
| Chemical events WHO | WHO | −20% |
| Radiation emergencies WHO | WHO | 0% |
| Legally-binding controls on lead paint WHO | WHO | – |
| Discharges from hospitals Eurostat | Eurostat | +6.5% |